Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rezolute

Clinical trials sponsored by Rezolute, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to tame tumor-triggered low blood sugar in rare cancer patients Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Promising new treatment for rare sugar disorder moves to final testing phase

Disease control Ongoing

This study tests an investigational drug called RZ358 for people with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. The trial involves 56 participants aged 3 months to 45 years who still have low blood sugar despite standard treatments. Over 24…

Phase 3 • Sponsor: Rezolute • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC